• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problems Material Invagination (1336); Material Too Rigid or Stiff (1544); Folded (2630)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/03/2017
Event Type  Injury  
Event Description
It was reported that during the first attempt at implantation of a perceval valve, at the level of the annulus showed an ¿impinchment.¿ this was described as an invagination or folding in the annulus.This was not solved with the ballooning or applying warm saline.The surgeon performed a second implantation with the same perceval valve.The valve again showed the same folding but in a different location.The valve was then replaced with an intuity valve.The size of the replacement valve was not provided.
 
Manufacturer Narrative
The gross examination was completed and showed evident deformation at the inflow ring in correspondence to the first leaflet.Visual examination showed that the shape of the valve in the returned status, appears irregular reasonably due to the manipulation during the implant / explant steps.Moreover, it has been observed a rigidity of all the leaflets.No other deformation has been highlighted through the x-ray analysis or dimensional analysis.The analysis performed reproducing the simulated use has shown the folding of the valve only for the minimum diameter available for the implant of the specific size 23.
 
Manufacturer Narrative
The device history record (dhr) review was completed on 5-sep-2017.Review of the data filed in the dhr confirmed that the returned perceval aortic heart valve sn# (b)(4) satisfied all material, dimensional, and performance standards required for perceval size 23/m at the time of manufacture and release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 fraser north way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 fraser north way
burnaby, bc 
MDR Report Key6411921
MDR Text Key70172314
Report Number3004478276-2017-00035
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)200726
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date07/26/2020
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/01/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/05/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/26/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-